Covaxin will get WHO nod at the earliest: Bharat Biotech

Bharat Biotech, the manufacturer of the indigenous vaccine against the corona epidemic, says that we will get the approval of the World Health Organization (WHO) as soon as possible. The company says that the review process for Covaxin’s vaccine has started and it may soon be approved for emergency use. Actually, in India, the corona vaccine vaccine is being used under emergency approval, but in other countries of the world, there is a problem in its use, because it has not been approved by the World Health Organization.

The WHO said last week that India can take a decision on including Biotech’s anti-Kovid-19 vaccine, Covaccine, in the list of emergency use in four to six weeks. WHO chief scientist Soumya Viswanathan said in a webinar of the Center for Science and Environment that Bharat Biotech, the manufacturer of the vaccine, is uploading all its data on our portal. WHO is reviewing this vaccine. EUL is a process as per WHO guidelines. Under this, new or unlicensed products can be used in public health emergencies.

Actually, there is a process of emergency clearance. In this, a company has to complete Phase III trials and submit all the data to WHO. They are studied by an expert group. These include safety and effectiveness and production quality standards. Bharat Biotech has already submitted the data. WHO has approved vaccines from Pfizer-BioNtech, AstraZeneca-SK Bio-Serum Institute of India, AstraZeneca EU, Janssen, Moderna and Sinopharm for emergency use.